The virus causes adult T cell leukemia/lymphoma (ATLL), an aggressive malignancy of CD4+ T lymphocytes in 1 to 5% of infected individuals that is refractory to most therapies [4]. Here, CD4 is linked to adult T-cell leukemia/lymphoma.